News
Cancer Study Headline, Translated: Progression-Free Survival
A plain-language research explainer for progression-free survival headlines and what patients should ask before applying the result.
Original commentary from the Cancer Explained editorial team.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
In brief
Progression-free survival describes how long people in a study lived without the cancer growing or spreading, but it is not the same as overall survival.
What this adds
The added value is a clear separation between a study endpoint and a personal prognosis.
Source table
| Source | What it can tell you | What it cannot decide for you |
|---|---|---|
| Trial publication or abstract | The endpoint definition and result | A personal treatment recommendation |
| NCI clinical trials information | How trials compare groups and phases | Whether the result changes standard care |
What this does not mean
- It does not replace the full source, trial publication, label, guideline, or care-team discussion.
- It does not tell one person what treatment, screening, or supportive-care decision is best.
- It does not mean a headline applies to every cancer type, stage, age, biomarker profile, or personal risk level.
Questions patients can ask
- Was progression-free survival the main endpoint?
- Did overall survival or quality of life also improve?
- Were people in the trial similar to me?
How this article was prepared
Prepared by Cancer Explained's AI-assisted editorial system and checked against the official sources listed below. This article has not been reviewed by a healthcare professional unless a named reviewer is specifically shown.
Found an error, a broken source link, outdated information, or wording that feels unsafe or unclear? Report it here.